Contact: Hilary Glover hilary.glover@biomedcentral.com 44-020-319-22370 BioMed Central
Cytomegalovirus (CMV) is one of the viruses that most infected people carry without ill effects. Once infected you are infected for life and, although it normally is dormant, it can become active again at any point in time. New research published in BioMed Central’s open access journal Immunity and Ageing shows that CMV infection is a significant risk factor for the type 2 diabetes in the elderly.
Obesity, inactivity and aging are known to be associated with insulin resistance, one of the first signs of incipient diabetes. However only a third of those with insulin resistance go on the develop type 2 diabetes. So what marks these people as different? Why do their pancreas’ fail? Genetic and environmental factors are thought to play a part but so also does inflammation. People with type 2 diabetes usually have raised levels of biological markers for inflammation such as elevated CRP and larger numbers of active white blood cells.
Chronic infections including CMV can ‘stress’ the immune system and when researchers from Leiden University Medical Centre and University of Tubingen Medical School compared glucose regulation with antibodies to CMV (or CMV seropositivity) in over 500 participants of the Leiden 85-plus Study they found that having CMV was associated with type 2 diabetes.
The researchers suggest that CMV could be either acting directly on pancreatic cells or indirectly by causing the immune system attacking the pancreas. Dr Andrea Maier, who led the investigation explained, ” In our study we realised that although CMV seropositivity was associated with type 2 diabetes, higher levels of HnA1c and high non-fasting glucose the actual level of antibodies against CMV was not. ”
This study is looking at the effect of CMV on the very old. By their very nature these people have had longer to become infected with CMV and have low risks for other factors which are linked to diabetes or to cardiovascular disease. While it may not be possible to extrapolate these findings to the general population it seems likely that finding a way to overcome CMV infections may reduce diseases, such as diabetes, later in life.
Media contact
Dr Hilary Glover Scientific Press Officer, BioMed Central Tel: +44 (0) 20 3192 2370 Mob: +44 (0) 778 698 1967 Email: hilary.glover@biomedcentral.com
Notes to Editors
1. Cytomegalovirus seropositivity is associated with glucose regulation in the oldest old. Results from the Leiden 85-plus Study Sijia Chen, Anton JM de Craen, Yotam Raz, Evelyna Derhovanessian, Ann CTM Vossen, Westendorp GJ Rudi, Graham Pawelec and Andrea B MaierImmunity & Ageing (in press)
Please name the journal in any story you write. If you are writing for the web, please link to the article. All articles are available free of charge, according to BioMed Central’s open access policy.
Article citation and URL available on request on the day of publication.
2. Immunity & Ageing is an open access, peer-reviewed, online journal that considers manuscripts on all aspects of ageing examined from an immunological point of view.
3. BioMed Central (http://www.biomedcentral.com/) is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector. @BioMedCentral